Sigma Planning Corp Alaunos Therapeutics, Inc. Transaction History

Sigma Planning Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	SELL	$0.62 - $1.17 $45,260 - $85,410	-73,000 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$1.09 - $1.89 $19,282 - $33,434	17,690 Added 31.98%	73,000 $80,000
Q3 2021 Oct 28, 2021	BUY	$1.44 - $2.73 $79,646 - $150,996	55,310 New	55,310 $101,000
Q1 2021 May 06, 2021	SELL	$2.82 - $5.6 $47,235 - $93,800	-16,750 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$2.09 - $3.09 $11,913 - $17,613	-5,700 Reduced 25.39%	16,750 $42,000

Q3 2020 Nov 03, 2020	BUY	$2.39 - $3.43 $11,233 - $16,121	4,700 Added 26.48%	22,450 $57,000
Q2 2020 Jul 31, 2020	BUY	$2.2 - $3.71 $10,450 - $17,622	4,750 Added 36.54%	17,750 $58,000
Q1 2020 May 01, 2020	BUY	$1.9 - $4.98 $24,700 - $64,740	13,000 New	13,000 $32,000
Q3 2019 Nov 01, 2019	SELL	$4.13 - $6.94 $113,079 - $190,017	-27,380 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$3.98 - $6.2 $108,972 - $169,756	27,380 New	27,380 $160,000

106K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $136M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.